Clinical Trials Browser

Phase 3 × Solid Tumor Malignancies × pembrolizumab × Clear all

NCT07174453 2025-12-08

Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies

Phase 3 Recruiting

Other solid neoplasm

Solid Tumor Malignancies